The research group led by Prof. Alex Schier, Director of the University of Basel’s Biozentrum, has identified 30 genes associated with schizophrenia.
The team was able to show which pathological changes in the brain and behavioral abnormalities are triggered by these genes. The results of the study have now been published in Cell.
The research team led by Prof. Alex Schier, Director of the Biozentrum, University of Basel, and currently group leader at Harvard University in Cambridge, investigated a total of 132 genes associated with schizophrenia. The potential connection to schizophrenia was confirmed for 30 genes. In zebrafish, the researchers found that errors in these genes impair the development or function of the brain and lead to behavioral abnormalities.
Regions in the genome under suspicion
Schizophrenia is a psychosis that leads to a disturbed perception of reality. This includes hearing voices, hallucinations or delusions. Although the disease can be treated with medication, it is currently incurable. Genetic changes that manifest themselves in the brain can cause schizophrenia. Previous studies have shown that several regions of the genome containing a variety of genes are associated with the disease.
Perpetrator profile of 30 genes
Alex Schier’s team has now identified 30 genes in these regions and has been able to show that they have concrete effects on the structure and function of the brain as well as on various behavioral patterns. “Of the 132 suspects, we were ultimately able to establish a more precise perpetrator profile for 30 genes,” said Schier. “One of the perpetrators is the transcription factor znf536, which controls the development of the forebrain. This brain region influences our social behavior and the processing of stress.” The research team not only deciphered the function of the individual genes, but also generated an atlas of all genes with their respective consequences for the brain.
In the crosshair of research
“The question of how the individual genes trigger schizophrenia remains open,” says Schier. “It would be possible to investigate whether the genes we identified change similar brain regions in patients as in zebrafish.” These genes and brain regions could then become new targets for drug therapies.
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
- Childhood ADHD Increases Risk Of Developing Schizophrenia Or Other Psychotic Disorderson February 28, 2021 at 7:17 am
Childhood attention-deficit/hyperactivity disorder (ADHD) is linked to an increase risk of psychotic disorders such as schizophrenia, according to a recent study published in JAMA Psychiatry.
- EastEnders' Lola to upset Isaac over his schizophreniaon February 26, 2021 at 5:51 pm
Lola Pearce will have a misunderstanding with Isaac Baptiste in EastEnders next week. Isaac (Stevie Basaula) has been holding back from fully opening up to girlfriend Lola (Danielle Harold) because of ...
- The impact of creativity on functional outcome in schizophrenia: a mediational modelon February 26, 2021 at 5:56 am
Functional impairment remains one of the most challenging issues for treatment in schizophrenia. However, previous studies have mainly focused on the negative impact of symptoms excluding variables ...
- Study reveals information about risk genes in schizophreniaon February 25, 2021 at 10:31 pm
Dr. Felix-Martin Werner, working at the Euro Academy Pößneck in Germany and Prof. Rafael Coveñas, working at the Institute of Neurosciences of Castilla and León, Salamanca in Spain, have been working ...
- Risk genes in schizophrenia - their importance in choosing appropriate antipsychotic drugon February 25, 2021 at 11:44 am
The objective of this review is to update the main risk genes involved in schizophrenia and to establish an association between the single nucleotide polymorphisms (SNPs) of these genes and ...
- A hybrid deep neural network for classification of schizophrenia using EEG Dataon February 25, 2021 at 4:08 am
Schizophrenia is a serious mental illness that causes great harm to patients, so timely and accurate detection is essential. This study aimed to identify a better feature to represent ...
- PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophreniaon February 25, 2021 at 4:00 am
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, develo ...
- Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophreniaon February 24, 2021 at 2:14 pm
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological ...
- Phase II Results Promising for New Schizophrenia Drug Comboon February 24, 2021 at 2:01 pm
Phase II results appear promising for a new combination treatment for schizophrenia. Findings from previous studies have shown that the muscarinic receptor agonist xanomeline could be used as a novel ...
- Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period - by PMIon February 24, 2021 at 7:08 am
The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of 2.7%. Primary factors driving the growth of the ...
via Bing News